Global Transcatheter Aortic Valve Implantation Market: Overview Transcatheter aortic valve implantation (TAVI), also referred as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure conducted in order to treat high-risk patients suffering from aortic stenosis. These high-risk patients cannot undergo operation or surgical aortic valve replacement (SAVR) procedure. Read Report Overview - https://www.transparencymarketresearch.com/transcatheter-aortic-valveimplantation-market.html The geriatric population are among the high-risk category patients, as it is very risky to conduct openheart procedure on them. In the TAVR procedure, implantation of transcatheter aortic valves is carried out to rejuvenate the blood circulation capability of the aortic valves. Demand for transcatheter aortic valve implantation is increasing owing to rise in prevalence of aortic stenosis. Global Transcatheter Aortic Valve Implantation Market: Key Trends The global transcatheter aortic valve implantation (TAVI) market is driven by increase in geriatric population, technological advancements in transcatheter aortic valves, and high adoption rate of TAVI devices. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=64934 Additionally, increase in the number of patients suffering from CVDs such as coronary artery diseases, hypertension, or heart failure, rise in the adoption of minimally invasive procedures, reduction in hospital stay duration, and lower risk of infection boost market growth. Global Transcatheter Aortic Valve Implantation Market: Segmentation The global transcatheter aortic valve implantation market can be segmented based on procedure and region. In terms of procedure, the market can be classified into transfemoral implantation, transapical implantation, and transaortic implantation. The transfemoral implantation segment accounted for the largest market share in 2018 and the trend is projected to continue during the forecast period. Global Transcatheter Aortic Valve Implantation Market: Regional Analysis Based on region, the global transcatheter aortic valve implantation market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to capture major market share owing to increase in health care investments by manufacturers and high R&D expenditure by companies for the development of these devices. Additionally, rise in prevalence of coronary artery diseases, hypertension, or heart failure fuels the growth of the transcatheter aortic valve implantation market in North America. Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php? flag=CR&rep_id=64934 Israel is an emerging market for TAVI due to large geriatric population and high unmet needs. This in turn is expected to boost the growth of the market in the Middle East. Major players are investing in the Middle East owing to lack of facilities and high demand for treatment devices. Moreover, rapid
Transcatheter Aortic Valve Implantation Market to Surge at a Robust Pace by 2027
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.